Pharmaceutical Technology

OCTOBER 7, 2022

The US Food and Drug Administration (FDA) is presently reviewing teplizumab for the delay of clinical T1D in people who are at risk. Simultaneously, the companies have signed a securities purchase agreement under which Sanofi will procure $35m of Provention’s common stock on teplizumab, obtaining FDA approval. .

Food and Drug Administration 119

Food and Drug Administration Healthcare Provider FDA Prospecting 119

Legacy MEDSearch

MAY 24, 2023

iHealthScreen conducted a prospective trial in the general population to prospectively assess the product’s accuracy, sensitivity and specificity. These prospective study results were initially presented at the Annual Meeting of the American Academy of Ophthalmology (AAO) and selected for Panel Discussion as outstanding work.

FDA 52

FDA Prospecting Recruitment Healthcare 52

Rep-Lite

MAY 10, 2024

From groundbreaking advancements in technology to a growing emphasis on patient-centricity, the industry is constantly evolving. The proliferation of telehealth solutions has led to a significant rise in virtual sales interactions and consultations, with healthcare providers and decision-makers embracing remote communication channels.

Medical sales 52

Medical sales Sales Medical Medical sales reps 52

Rep-Lite

MARCH 14, 2024

Medical sales representatives are the medium through which medical companies sell their healthcare products to providers like hospitals and clinics. They build relationships, understand needs, and offer tailored solutions to these healthcare providers.

Medical sales reps 52

Medical sales reps Medical sales Sales Medical 52

Rep-Lite

NOVEMBER 30, 2023

B2B sales consultants in medical sales often work on strategies for nurturing long-term relationships with healthcare providers, which may differ significantly from the transactional nature of traditional sales. It ensures you invest your time and resources in prospects with the highest potential. This is how you bring value.

B2B Sales 52

B2B Sales Medical sales Consulting Sales 52

Legacy MEDSearch

JANUARY 3, 2023

Burning Rock, a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, announced that its OverC Multi-Cancer Detection Blood Test (MCDBT) has been granted Breakthrough Device Designation by the US Food and Drug Administration (FDA), which is the third of its kind globally.

FDA 95

FDA Food and Drug Administration Recruitment Prospecting 95

pharmaphorum

NOVEMBER 22, 2022

Patients with fibromyalgia – a common condition causing chronic pain, fatigue, poor sleep, and cognitive dysfunction – could get relief from a digital therapeutic (DTx) based on cognitive behavioural therapy, according to a clinical trial. It is available on prescription from healthcare providers.

Pharmacology 111

Pharmacology Patients Healthcare Provider Prescription 111